Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 19, 2025 07:00 ET | Source: BioXcel Therapeutics

BioXcel Therapeutics Announces Database Lock in SERENITY At-Home Pivotal Phase 3 Safety Trial for Acute Treatment of Agitation Associated with Bipolar Disorders or Schizophrenia

Data from more than 2,600 agitation episodes collected Topline data readout is on track for August NEW HAVEN, Conn., Aug. 19, 2025 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq:...
August 18, 2025 10:00 ET | Source: Mount Sinai Press Office

Mount Sinai Returns as Official Hospital and Medical Services Provider of the US Open Tennis Championships

New York, NY, Aug. 18, 2025 (GLOBE NEWSWIRE) -- New York, NY (August 15, 2025) Mount Sinai is celebrating its 13th year as the official hospital and medical services provider of the US Open Tennis...
August 18, 2025 09:47 ET | Source: Hapbee Technologies, Inc.

Hapbee Secures Strategic Backing and Commercial Agreement to Enter Multi-Billion Dollar Asian Wellness Market

VANCOUVER, British Columbia, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Hapbee Technologies Inc. (“Hapbee” or the “Company”) (TSXV: HAPB | OTCQB: HAPBF | FWB: HA1) today announced that Smile Group, a...
August 18, 2025 08:10 ET | Source: NRx Pharmaceuticals, Inc.

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reports Second Quarter 2025 Financial Results and Provides Corporate Update

NRx Drug Development Grant of expanded Fast Track Designation for NRX-100 from the FDA for all indications and types of depression and related disorders based on its potential to satisfy an unmet...
August 18, 2025 07:00 ET | Source: BioXcel Therapeutics

BioXcel Therapeutics Announces Positive FDA Pre-sNDA Meeting Comments for sNDA Submission for BXCL501 in Agitation Associated with Bipolar Disorders or Schizophrenia

Achieved alignment with the FDA on sNDA package to expand the IGALMI label for the At-Home (Outpatient) setting sNDA submission on track for Q1 2026 NEW HAVEN, Conn., Aug. 18, 2025 (GLOBE...
August 15, 2025 10:32 ET | Source: IMG Academy

SURVEY: Parents Overwhelmingly Want College Sports to Teach Life Skills and Improve College Outcomes

BRADENTON, Fla., Aug. 15, 2025 (GLOBE NEWSWIRE) -- In the wake of the House v. NCAA settlement and growing concerns over the future of collegiate Olympic sports, a new nationwide survey of more than...
August 14, 2025 17:43 ET | Source: Guardian Angels Medical Service Dogs, Inc.

PNC Bank Announced as Gold Sponsor for the 2025 National Mutt Strut Benefiting Guardian Angels Medical Service Dogs

Pittsburgh, PA, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Guardian Angels Medical Service Dogs is proud to announce PNC Bank as the Gold Sponsor of the 2025 National Mutt Strut, a virtual event launching...
August 14, 2025 12:18 ET | Source: Cloud9

Cloud9 Announces Availability of Daily Restore, a Plant-Based Supplement for Nutrient Replenishment and Balance

Miami, Aug. 14, 2025 (GLOBE NEWSWIRE) -- This content is for informational purposes only and is not intended as medical advice. Cloud9 Daily Restore is a dietary supplement and is not intended to...
August 14, 2025 09:00 ET | Source: Manatt, Phelps & Phillips, LLP

Manatt Welcomes Addiction Medicine and Substance Use Disorder Leader as National Advisor in Washington, D.C.

WASHINGTON, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Manatt, Phelps & Phillips, LLP, a multidisciplinary, integrated professional services firm, today announced the arrival of National Advisor Dr....
August 14, 2025 08:00 ET | Source: PharmaTher Holdings Ltd.

PharmaTher Founder and CEO Issues Letter to Shareholders following the FDA Approval of Ketamine (KETARx™)

TORONTO, Aug. 14, 2025 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a specialty pharmaceutical company focused on unlocking the...